Expanded Size Matrix Cleared for TriReme Medical's Glider PTCA Balloon Catheter

July 16, 2012—TriReme Medical, Inc. (Pleasanton, CA) announced that it has received clearance from the US Food and Drug Administration for an expanded matrix of sizes for the Glider percutaneous transluminal coronary angioplasty balloon catheter. Glider is now approved for the treatment of lesions in the coronary vasculature in balloon diameters from 1.5 to 3.5 mm and lengths from 4 to 20 mm.

"Glider provides interventional cardiologists with an entirely new degree of control during the treatment of complex side branches and total occlusions," commented David Rizik, MD, Medical Director at Scottsdale Heart Group in Scottsdale, Arizona. "With its torqueable shaft and ultra short 4-mm length, I am amazed that such a clever design can provide such powerful clinical benefits. Glider has become my 'go-to' balloon when I approach the treatment of my most challenging cases."